NIH-funded research R01 grant

Understanding why DCIS becomes invasive breast cancer in Asian American and Native Hawaiian/Pacific Islander groups

Official title: Identification of Biological Mechanisms and Risk Factors Contributing to Progression of DCIS to Invasive Breast cancer among AANHPI Populations.

Funded at University of Hawaii at Manoa · NIH-11449258 · Data updated 2026-11-12

A research project aims to identify biological factors and risk patterns that predict when early-stage DCIS may progress to invasive breast cancer, with a focus on AANHPI populations.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Hawaii at Manoa
NIH-funded
Lab location1 site (Honolulu, United States)
Project startAugust 13, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$555,703
NIH project number1R01CA301785-01A1
Project IDNIH-11449258 on NIH RePORTER

Who could benefit from this research

Could help

Individuals diagnosed with DCIS, especially those identifying as Asian American or Native Hawaiian/Pacific Islander, who are willing to share clinical, lifestyle, and tumor data for follow-up.

Less likely to help

Patients with DCIS who do not progress to invasion may see limited immediate benefit if risk stratification does not change their treatment.

What this research studies

This project follows people with ductal carcinoma in situ (DCIS) to find markers and risk factors that distinguish indolent cases from those likely to progress to invasive cancer, especially in Asian American and Native Hawaiian/Pacific Islander groups. Researchers will analyze clinical data, tumor characteristics, lifestyle factors, and sociodemographic information to identify high-risk profiles. The study uses follow-up of patients treated for DCIS to understand long-term outcomes and potential disparities. By clarifying who is at higher risk, doctors could tailor treatment to reduce over- or under-treatment.

Why it matters

Potential benefit: If successful, the project could lead to more personalized DCIS treatment plans that prevent overtreatment and improve early detection of progression for at-risk patients.

How similar studies have gone: Prior work suggests racial/ethnic differences exist in DCIS progression, supporting the potential for meaningful findings with larger multiethnic analyses.

Where this research is happening

  • University of Hawaii at Manoa
    Honolulu, United States
    Active

Researchers

  • Principal investigator: Loo, Lenora Wm — University of Hawaii at Manoa
  • Study coordinator: Loo, Lenora Wm

Related research

Other NIH-funded projects on the same topics.

  • Imaging test to show whether non-invasive breast tumor treatment has worked

    This project is creating a non-contrast MRI tool powered by AI to quickly show if focused ultrasound has destroyed a localized breast tumor for people with early-stage breast cancer.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11251261

  • A new imaging method to assess tissue health during breast cancer treatment

    This study is testing a new way to check how well breast cancer treatments are working by using special MRI scans that don’t require any injections, helping doctors see if the tumor is responding to treatment and making sure patients get the best care possible.

    NIH research University of Utah · Salt Lake City, United States · NIH-11009526

  • Exploring how environmental factors may increase the risk of breast cancer

    This study is looking at how things in our environment, like air pollution and alcohol, might affect the risk of breast cancer by checking for specific markers in the blood, and it's designed for women who want to understand more about these potential links.

    NIH research Northwestern University at Chicago · Chicago, United States · NIH-11003304

  • Using advanced MRI techniques to improve breast cancer treatment.

    This study is working on improving breast cancer treatment by using new MRI techniques that combine advanced technology and machine learning, so patients can get clearer images of how well their treatments are working, leading to better care and outcomes.

    NIH research University of Utah · Salt Lake City, United States · NIH-10997959

  • Investigating how a specific protein contributes to the progression of breast cancer

    This study is looking at a protein called cyclin E and how its changes might lead to aggressive breast cancer, with the hope that understanding these early changes can help improve early detection and treatment options for patients.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-10550153

  • Examining disparities in breast cancer progression and healthcare

    This study is looking at how breast cancer affects different racial and ethnic groups, especially African American and Hispanic communities, to find out why some people face more challenges in getting care and how we can improve health outcomes for everyone.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-10432316

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.